DOJ Seeks Comments on Bulletproof Vest Grant Forms
Published Date: 6/30/2026
Notice
Summary
The Department of Justice is updating the paperwork for the Patrick Leahy Bulletproof Vest Partnership Program, which helps law enforcement get bulletproof vests. They want your feedback on the changes and how easy the new forms are to use. Comments are open for 30 days until July 30, 2026, so don’t miss your chance to weigh in!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Application Paperwork and Time Burden
If you apply for the Bulletproof Vest Partnership Program, responding to the information collection is required to obtain or retain benefits. The notice lists an Estimated Time per Respondent of 4273 and a Total Estimated Annual Time Burden of 4273 hours, and DOJ seeks Paperwork Reduction Act authorization for three (3) years; comments are accepted until July 30, 2026.
50% Federal Vest Cost Share
If you are a jurisdiction or law enforcement agency with armor vest needs, you may request funds to help purchase one bulletproof vest per officer per fiscal year. Federal payment covers up to 50 percent of each jurisdiction's local costs for those vests.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-13145 — Importer of Controlled Substances Application: Almac Clinical Services Incorp. (ACSI)
Almac Clinical Services Incorp. (ACSI) wants to become an official importer of certain controlled substances, including psilocybin and oxycodone. This affects drug manufacturers and others in the industry who can comment or request a hearing by July 30, 2026. No direct costs are mentioned, but the decision could impact how these substances enter the U.S. market.
2026-13149 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-National Motor Vehicle Title Information System (NMVTIS)
The Department of Justice wants to update how it collects info for the National Motor Vehicle Title Information System (NMVTIS), which helps track car titles and prevent fraud. They’re asking for public feedback by July 30, 2026, to make sure the process is clear, useful, and not too much work. This update affects anyone who reports or uses vehicle title info and aims to keep things smooth and efficient without extra costs.
2026-13144 — Importer of Controlled Substances Application: Catalent Pharma Solutions, LLC
Catalent Pharma Solutions wants to become an official importer of some powerful controlled substances like LSD and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by July 30, 2026. This move could impact companies involved in these substances and the government’s control over them.
Previous / Next Documents
Previous: 2026-13149 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Title-National Motor Vehicle Title Information System (NMVTIS)
The Department of Justice wants to update how it collects info for the National Motor Vehicle Title Information System (NMVTIS), which helps track car titles and prevent fraud. They’re asking for public feedback by July 30, 2026, to make sure the process is clear, useful, and not too much work. This update affects anyone who reports or uses vehicle title info and aims to keep things smooth and efficient without extra costs.
Next: 2026-13151 — Certain Heavy Machinery and Components Thereof; Notice of Institution of Investigation
Caterpillar Inc. has asked the U.S. International Trade Commission to investigate certain imported heavy machinery and parts that might be using their patented technology without permission. If the investigation finds problems, it could lead to orders stopping these products from entering or being sold in the U.S., which could shake up the market soon. This all kicked off officially on June 25, 2026, so keep an eye out for changes that might affect companies and buyers.